PFO Closure Products Lose “Humanitarian Device” Status
This article was originally published in The Gray Sheet
Executive SummaryNMT Medical has a step up on patent foramen ovale closure competitor AGA Medical after both firms got word from FDA that they should remove their limited-release stroke treatments from the U.S. market
You may also be interested in...
WL Gore's Cardioform Septal Occluder is now the second device to gain PMA approval to close the patent foramen ovale heart defect, to help prevent repeat ischemic stroke, according to FDA's website.